Rhabdomyosarcoma, Embryonal
"Rhabdomyosarcoma, Embryonal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of RHABDOMYOSARCOMA arising primarily in the head and neck, especially the orbit, of children below the age of 10. The cells are smaller than those of other rhabdomyosarcomas and are of two basic cell types: spindle cells and round cells. This cancer is highly sensitive to chemotherapy and has a high cure rate with multi-modality therapy. (From Holland et al., Cancer Medicine, 3d ed, p2188)
MeSH Number(s)
C04.557.450.590.550.660.675
C04.557.450.795.550.660.675
Concept/Terms
Rhabdomyosarcoma, Embryonal- Rhabdomyosarcoma, Embryonal
- Embryonal Rhabdomyosarcoma
- Embryonal Rhabdomyosarcomas
- Rhabdomyosarcomas, Embryonal
Below are MeSH descriptors whose meaning is more general than "Rhabdomyosarcoma, Embryonal".
Below are MeSH descriptors whose meaning is more specific than "Rhabdomyosarcoma, Embryonal".
This graph shows the total number of publications written about "Rhabdomyosarcoma, Embryonal" by people in Harvard Catalyst Profiles by year, and whether "Rhabdomyosarcoma, Embryonal" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 5 | 0 | 5 |
| 2000 | 2 | 0 | 2 |
| 2001 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 2 | 1 | 3 |
| 2008 | 1 | 2 | 3 |
| 2011 | 2 | 2 | 4 |
| 2012 | 2 | 0 | 2 |
| 2013 | 6 | 0 | 6 |
| 2014 | 5 | 0 | 5 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 1 | 2 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 7 | 0 | 7 |
Below are the most recent publications written about "Rhabdomyosarcoma, Embryonal" by people in Profiles.
-
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study. JCO Precis Oncol. 2022 Oct; 6:e2100534.
-
Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcoma. Br J Cancer. 2022 11; 127(11):1939-1953.
-
Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcoma. Nat Cancer. 2022 08; 3(8):961-975.
-
Embryonal Rhabdomyosarcoma of the Uterine Cervix: A Clinicopathologic Study of 94 Cases Emphasizing Issues in Differential Diagnosis Staging, and Prognostic Factors. Am J Surg Pathol. 2022 Nov 01; 46(11):1477-1489.
-
Therapeutic targeting of ATR in alveolar rhabdomyosarcoma. Nat Commun. 2022 07 25; 13(1):4297.
-
The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma. Dev Cell. 2022 05 23; 57(10):1226-1240.e8.
-
Cutaneous mosaic RASopathies associated with rhabdomyosarcoma. Pediatr Blood Cancer. 2022 05; 69(5):e29639.
-
An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials. Pediatr Blood Cancer. 2022 04; 69(4):e29511.
-
Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations. Mod Pathol. 2021 09; 34(9):1750-1762.
-
MYOD1 as a prognostic indicator in rhabdomyosarcoma. Pediatr Blood Cancer. 2021 09; 68(9):e29085.